Recommendation of the President – next-generation sequencing of the human genom
On 27 March 2026, the President of the Agency for Health Technology Assessment and Tariff System issued recommendation No. 27/2026 on the assessment of the appropriateness of classifying next-generation sequencing of the human genome for the diagnosis of diseases caused by germline mutations as a guaranteed service within the scope of outpatient specialty care